NCT07678944Completed
Impact of Exercise Prescription on Obstetric and Neonatal Outcomes
Source: ClinicalTrials.gov · Last updated 2 Jul 2026
Brief summary (registry, in English)
The aim of this study is to assess the impact of structured physical activity with smartwatch remote monitoring on glycemic control, blood pressure control, obstetric complications and neonatal outcomes in women with GDM, chronic hypertension and obesity. A prospective, longitudinal, single-arm intervention study with 310 pregnant women was conducted over a period of 18 months. Participants received individualized exercise prescriptions based on international guidelines, complemented by smartwatch monitoring and regular telephonic feedback. Outcomes were compared between subgroups of women who adhere to the recommended exercise guidelines and those who did not, across three high-risk populations (GDM, chronic hypertension and obesity).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 310 (actual)
- First submitted
- 19 Jun 2026
- Start date
- 1 Feb 2024
- Primary completion date
- 1 Feb 2025
- Lead sponsor
- Unidade Local de Saúde de Coimbra, EPE
- Diseases
- Obesity, High blood pressure
- NCT number
- NCT07678944
What you commit to
- Study type: Interventional
- Participants enrolled: 310
- From 1 Feb 2024 to the primary completion date, 1 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- history of premature delivery due to a non-maternal cause
- persistent vaginal bleeding
- cervical insufficiency
- any limiting systemic, respiratory or cardiovascular disease.
Other
- multiple gestations
- risk of preterm labor
- placenta previa beyond 28 weeks' gestation
Who the study is looking for
- Pregnant women aged 16 years or older with a confirmed diagnosis of gestational diabetes (fasting blood glucose greater than 92 mg/dL in first trimester; or values in the oral glucose tolerance test in second trimester greater than 92/180/153 mg/dL, respectively at 0 hours, 1 hour after glucose ingestion, and 2 hours after)
- Pregnant women aged 16 or older with chronic hypertension or a history of bariatric surgery and pre-pregnancy Body Mass Index (BMI) above 30Kg/m2.
- Eligibility further required consistent clinical adherence defined as attending all schedule appointments with the obstetric team without unjustified absences
Age in the registry: 16 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ULSCoimbra Coordinator of this site? Confirm its status | Coimbra | Portugal | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.